The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of 94.5% as Phase 3 research continues.
The institute is participating in NIAID tests of Moderna and Johnson & Johnson vaccines.
KPWHRI psychologist and researcher Ben Balderson, PhD, shares advice for keeping our spirits up during this most unusual holiday season.
We study health and health care as it happens in everyday settings by everyday people, producing results that are built to work in the real world. We share our results in the public domain to benefit people everywhere.